Regulatory network analysis of microRNAs and genes in imatinib-resistant chronic myeloid leukemia
Autor: | Mouheb Teber, Hanen Gharbi, Kais Douzi, Islem Ben Hassine, Ghada Bouguerra, Samia Menif, Salem Abbes, Ismael Soltani |
---|---|
Rok vydání: | 2016 |
Předmět: |
0301 basic medicine
Genetics ABL medicine.medical_treatment Gene regulatory network breakpoint cluster region Myeloid leukemia General Medicine Biology Targeted therapy MicroRNAs 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Imatinib mesylate Leukemia Myelogenous Chronic BCR-ABL Positive hemic and lymphatic diseases 030220 oncology & carcinogenesis microRNA Imatinib Mesylate medicine Humans Gene |
Zdroj: | Functional & Integrative Genomics. 17:263-277 |
ISSN: | 1438-7948 1438-793X |
Popis: | Targeted therapy in the form of selective breakpoint cluster region-abelson (BCR/ABL) tyrosine kinase inhibitor (imatinib mesylate) has successfully been introduced in the treatment of the chronic myeloid leukemia (CML). However, acquired resistance against imatinib mesylate (IM) has been reported in nearly half of patients and has been recognized as major issue in clinical practice. Multiple resistance genes and microRNAs (miRNAs) are thought to be involved in the IM resistance process. These resistance genes and miRNAs tend to interact with each other through a regulatory network. Therefore, it is crucial to study the impact of these interactions in the IM resistance process. The present study focused on miRNA and gene network analysis in order to elucidate the role of interacting elements and to understand their functional contribution in therapeutic failure. Unlike previous studies which were centered only on genes or miRNAs, the prime focus of the present study was on relationships. To this end, three regulatory networks including differentially expressed, related, and global networks were constructed and analyzed in search of similarities and differences. Regulatory associations between miRNAs and their target genes, transcription factors and miRNAs, as well as miRNAs and their host genes were also macroscopically investigated. Certain key pathways in the three networks, especially in the differentially expressed network, were featured. The differentially expressed network emerged as a fault map of IM-resistant CML. Theoretically, the IM resistance process could be prevented by correcting the included errors. The present network-based approach to study resistance miRNAs and genes might help in understanding the molecular mechanisms of IM resistance in CML as well as in the improvement of CML therapy. |
Databáze: | OpenAIRE |
Externí odkaz: |